Yajing Yang
Amgen (United States)(US)Fudan University(CN)Université Bourgogne Franche-Comté(FR)
Publications by Year
Research Areas
Liver physiology and pathology, Seaweed-derived Bioactive Compounds, Epigenetics and DNA Methylation, Polysaccharides and Plant Cell Walls, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1(2022)225 cited
- → AMG 757, a Half-Life Extended, DLL3-Targeted Bispecific T-Cell Engager, Shows High Potency and Sensitivity in Preclinical Models of Small-Cell Lung Cancer(2020)224 cited
- → Discovery and Optimization of Triazolopyridazines as Potent and Selective Inhibitors of the c-Met Kinase(2008)139 cited
- → c-Met Inhibitors with Novel Binding Mode Show Activity against Several Hereditary Papillary Renal Cell Carcinoma-related Mutations(2007)137 cited
- → Structure-Based Design of Novel Class II c-Met Inhibitors: 2. SAR and Kinase Selectivity Profiles of the Pyrazolone Series(2012)74 cited
- → TET2 Suppresses VHL Deficiency-Driven Clear Cell Renal Cell Carcinoma by Inhibiting HIF Signaling(2022)66 cited